Sara M Centuori

发表

HP_A_217569 53..63

S. Parthasarathy, Jesse D. Martinez, Nathan W. Sweeney, 2019 .

Hypoxia Suppresses High Fat Diet-Induced Steatosis And Development Of Hepatic Adenomas

S. Parthasarathy, Jesse D. Martinez, Nathan W. Sweeney, 2019, Hypoxia.

Dependent Mechanism - g Tumor Killing Activity by an IFN-Th-1 Lymphocytes Induce Dendritic Cell

Elaine, B. Bonnotte, D. Alizadeh, 2011 .

Th-1 Lymphocytes Induce Dendritic Cell Tumor Killing Activity by an IFN-γ–Dependent Mechanism

B. Bonnotte, D. Alizadeh, N. Larmonier, 2011, The Journal of Immunology.

Comparative analysis of 14-3-3 isoform expression and epigenetic alterations in colorectal cancer

Jesse D. Martinez, Vijayababu M. Radhakrishnan, Cecil J. Gomes, 2015, BMC Cancer.

Myeloid‐derived suppressor cells from tumor‐bearing mice impair TGF‐β‐induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25−FoxP3− T cells

B. Bonnotte, D. Alizadeh, N. Larmonier, 2012, Journal of leukocyte biology.

Randomized Crossover Trial Evaluating Detoxification of Tobacco Carcinogens by Broccoli Seed and Sprout Extract in Current Smokers

M. Padi, E. Szabo, J. Bauman, 2022, Cancers.

Differential Regulation of EGFR–MAPK Signaling by Deoxycholic Acid (DCA) and Ursodeoxycholic Acid (UDCA) in Colon Cancer

Jesse D. Martinez, Sara M Centuori, 2014, Digestive Diseases and Sciences.

Increased PD‐L1 Expression in Human Skin Acutely and Chronically Exposed to UV Irradiation

E. Petricoin, S. Dickinson, C. Curiel-Lewandrowski, 2021, Photochemistry and photobiology.

c-Met Signaling as a Therapeutic Target in Head and Neck Cancer

J. Bauman, Sara M Centuori, 2022, Cancer journal.

Clinical trials optimizing investigator and self‐collection of buccal cells for RNA yield

J. Grandis, Hua Li, J. Bauman, 2021, Laryngoscope investigative otolaryngology.

cells for RNA yield.

J. Grandis, J. Bauman, D. Normolle, 2021 .

Double-negative (CD27−IgD−) B cells are expanded in NSCLC and inversely correlate with affinity-matured B cell populations

Jesse D. Martinez, C. Putnam, L. Garland, 2018, Journal of Translational Medicine.

A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance.

H. Parnes, P. Pinto, J. Schlom, 2022, European urology focus.

Deoxycholic acid mediates non-canonical EGFR-MAPK activation through the induction of calcium signaling in colon cancer cells.

Jesse D. Martinez, C. Putnam, Cecil J. Gomes, 2016, Biochimica et biophysica acta.

Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention

J. Bauman, C. Caulin, Sara M Centuori, 2021, Current Treatment Options in Oncology.

Locally produced autoantibodies in cancer

D. Bhattacharya, Sara M Centuori, 2022, Cell.

NEGATIVE REGULATION OF REGULATORY T CELLS BY MYELOID-DERIVED SUPPRESSOR CELLS IN CANCER

Sara M Centuori, 2011 .

The induction of endoreduplication and polyploidy by elevated expression of 14-3-3γ

Jesse D. Martinez, C. Putnam, C. Wolgemuth, 2017, Genes & cancer.

A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density

M. Altbach, J. Galons, C. Thomson, 2021, Breast Cancer Research and Treatment.

Measuring DNA content in live cells by fluorescence microscopy

Jesse D. Martinez, C. Wolgemuth, Cecil J. Gomes, 2018, Cell Division.

T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1

B. Bonnotte, S. Lemaire-Ewing, P. Saas, 2015, BioMed research international.

Measuring DNA content in live cells by fluorescence microscopy

Jesse D. Martinez, C. Wolgemuth, Cecil J. Gomes, 2018, Cell division.

Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer

J. Bauman, C. Caulin, B. Burtness, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HP_A_217569 53..63

S. Parthasarathy, Jesse D. Martinez, Nathan W. Sweeney, 2019 .

Immunotherapy to prevent progression on active surveillance study (IPASS): A phase II, randomized, double-blind, controlled trial of PROSTVAC in prostate cancer patients who are candidates for active surveillance.

Chiu-Hsieh Hsu, H. Parnes, J. Schlom, 2022, Journal of Clinical Oncology.